GHK-Cu (Copper Peptide)

How GHK Was Discovered

UKPWritten & reviewed by William Heath · Editor, UK Peptides research library2 min readLast reviewed 2026-08-233 cited sources

The short answer

Loren Pickart isolated GHK from the albumin fraction of human plasma in 1973, while investigating why plasma from younger donors caused liver tissue from older donors to synthesise proteins in a pattern more typical of younger tissue. The active component proved to be a tripeptide.

Key facts

Year
1973
Investigator
Loren Pickart
Source
Human plasma, albumin fraction
Original question
Young plasma altering older liver tissue
Early working name
Liver cell growth factor
Also indexed as
Prezatide

The observation that started it

The experiment was not looking for a peptide. Plasma from young donors was added to liver tissue from older donors, and the older tissue began producing proteins in a pattern more characteristic of younger tissue. Something in young plasma was doing it, and the work that followed was an attempt to find out what.

Why albumin

The activity tracked to the albumin fraction during separation. That is a meaningful detail rather than a procedural one: albumin is the major copper-transport protein in plasma and carries its own amino-terminal copper-binding site of the same class as GHK's. Finding a copper-binding tripeptide in the albumin fraction is consistent rather than coincidental.

Research material referenced

GHK-Cu 100mg, third-party HPLC tested

Buy GHK-Cu · £34.99

The early names

The peptide was described as liver cell growth factor for a period, reflecting the assay it was found in rather than any established function. It is also indexed under the name prezatide. Both names appear in older literature and searching for them surfaces records that a search for GHK misses.

What the original work did and did not establish

It established that a specific tripeptide, isolable from human plasma, altered protein synthesis in a tissue model. It did not establish a receptor, a physiological pathway, or an effect in an organism. Fifty years of subsequent work has substantially expanded the descriptive literature; the mechanistic picture remains built largely on copper delivery rather than on a defined signalling pathway.

Why it stayed interesting

Two features. It is endogenous, present in human plasma, unlike compounds whose endogenous status is asserted rather than demonstrated. And its concentration is reported to decline with age, which gives the observation a natural narrative. Both are real; neither establishes that administering it does anything.

Frequently asked questions

What was Pickart originally studying?

Why plasma from young donors changed protein synthesis in liver tissue from older donors. GHK was the fraction responsible.

Why was it called liver cell growth factor?

It reflected the assay in which the activity was found, not an established function. The name did not survive.

Is GHK endogenous?

Yes. It was isolated from human plasma, which distinguishes it from compounds whose endogenous status remains unconfirmed.

Continue researching

Peer-reviewed guides, comparators and matched reference materials.

Primary sources & clinical trials

Peer-reviewed research and registered trials from PubMed, ClinicalTrials.gov, PubChem, FDA and NIH. All links open in a new tab and point to the primary source, so every claim can be verified at origin.

Browse the wider literature

Live database searches, not fixed citations. Results change as new work is indexed.

UKP

Written and reviewed by

William Heath · Editor, UK Peptides research library

William Heath edits the UK Peptides research library. He is responsible for what is published here: every article is sourced to primary literature, every purity or identity statement traces to a signed third-party certificate for a specific lot, and corrections are made in place with the review date updated. No scientific or medical credentials are claimed on this site; the evidence is carried by the cited sources and the certificates, not by the byline.

More GHK-Cu (Copper Peptide) articles

Research use only. The information above is provided for scientific and educational reference. Compounds referenced are not approved for human use and are supplied for in vitro research or reference-material purposes only. No efficacy, safety, or therapeutic claims are made.